Literature DB >> 35199254

Adult-onset selective quadriceps femoris weakness in RYR1-related myopathy.

Aaron de Souza1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35199254     DOI： 10.1007/s10072-022-05964-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.830


× No keyword cloud information.
  5 in total

1.  Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study.

Authors:  B A Phillips; L A Cala; G W Thickbroom; A Melsom; P J Zilko; F L Mastaglia
Journal:  Muscle Nerve       Date:  2001-11       Impact factor: 3.217

2.  RYR1-related myopathies: a wide spectrum of phenotypes throughout life.

Authors:  M Snoeck; B G M van Engelen; B Küsters; M Lammens; R Meijer; J P F Molenaar; J Raaphorst; C C Verschuuren-Bemelmans; C S M Straathof; L T L Sie; I F de Coo; W L van der Pol; M de Visser; H Scheffer; S Treves; H Jungbluth; N C Voermans; E-J Kamsteeg
Journal:  Eur J Neurol       Date:  2015-05-11       Impact factor: 6.089

3.  Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.

Authors:  Heinz Jungbluth; Mark R Davis; Clemens Müller; Serena Counsell; Joanna Allsop; Arijit Chattopadhyay; Sonia Messina; Eugenio Mercuri; Nigel G Laing; Caroline A Sewry; Graeme Bydder; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2004-12       Impact factor: 4.296

4.  Genetic variation in RYR1 and malignant hyperthermia phenotypes.

Authors:  D Carpenter; R L Robinson; R J Quinnell; C Ringrose; M Hogg; F Casson; P Booms; D E Iles; P J Halsall; D S Steele; M-A Shaw; P M Hopkins
Journal:  Br J Anaesth       Date:  2009-07-31       Impact factor: 9.166

5.  Muscle MRI and functional outcome measures in Becker muscular dystrophy.

Authors:  Andrea Barp; Luca Bello; Luca Caumo; Paola Campadello; Claudio Semplicini; Annalisa Lazzarotto; Gianni Sorarù; Chiara Calore; Alessandro Rampado; Raffaella Motta; Roberto Stramare; Elena Pegoraro
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.